UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A 0/1h-algorithm using cardiac myosin-binding protein C for early diagnosis of myocardial infarction

European heart journal. Acute cardiovascular care, 2022-06, Vol.11 (4), p.325-335

2022

Volltextzugriff (PDF)

1,3,5-Triphosphabicyclo[3.1.0]hexene-η3,η1-diyl Hafnium Complexes: Structure and Reactivity

European journal of inorganic chemistry, 1999-05, Vol.1999 (5), p.763-769

1999

Volltextzugriff (PDF)

13C tracer analysis reveals the landscape of metabolic checkpoints in human CD8+ T cell differentiation and exhaustion

Frontiers in immunology, 2023-10, Vol.14, p.1267816-1267816

2023

Volltextzugriff (PDF)

14th International Conference of Archaeological Prospection

Archéosciences, 2021-08 (45)

2021

Volltextzugriff (PDF)

16(th) IHIW: extending the number of resources and bioinformatics analysis for the investigation of HLA rare alleles

International journal of immunogenetics, 2013-02, Vol.40 (1), p.60-65

2013

Volltextzugriff (PDF)

181 INTRO-study: intraperitoneal infusion of allogeneic stem-cell derived natural killer cells in recurrent ovarian carcinoma patients

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A299-A299

2024

Volltextzugriff (PDF)

The 1976C>T polymorphism in the adenosine A2A receptor gene does not affect the vasodilator response to adenosine in humans in vivo

Pharmacogenetics and genomics, 2007-07, Vol.17 (7), p.551-554

2007

Volltextzugriff (PDF)

2019 EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older

Annals of the rheumatic diseases, 2021-01, Vol.80 (1), p.57-64

2021

Volltextzugriff (PDF)

The 22G>A polymorphism in the adenosine deaminase gene impairs catalytic function but does not affect reactive hyperaemia in humans in vivo

Pharmacogenetics and genomics, 2008-10, Vol.18 (10), p.843-846

2008

Volltextzugriff (PDF)

2937: Dose deposition in sub-regions of breast relates to acute and persistent pain after radiotherapy

Radiotherapy and oncology, 2024-05, Vol.194, p.S693-S696

2024

Volltextzugriff (PDF)

320. PEDIATRIC OPEN-LABEL CLINICAL STUDY OF RITUXIMAB FOR THE TREATMENT OF GRANULOMATOSIS WITH POLYANGIITIS AND MICROSCOPIC POLYANGIITIS

Rheumatology (Oxford, England), 2019-03, Vol.58 (Supplement_2)

2019

Volltextzugriff (PDF)

IL‐33 polymorphisms are associated with increased risk of hay fever and reduced regulatory T cells in a birth cohort

Pediatric allergy and immunology, 2016-11, Vol.27 (7), p.687-695

2016

Volltextzugriff (PDF)

336.5: Modifying The Porcine Genome for Xeno-organ Transplantation

Transplantation, 2023-10, Vol.107 (10S2), p.136-137

2023

Volltextzugriff (PDF)

385 EFFECT OF RENAL NERVE ABLATION ON ARTERIAL STIFFNESS IN RESISTANT HYPERTENSION

Journal of hypertension, 2012-09, Vol.30 Suppl 1 (Supplement 1), p.e113-e113

2012

Volltextzugriff (PDF)

4‑(Difluoromethyl)-5-(4-((3R,5S)‑3,5-dimethylmorpholino)-6-((R)‑3-methylmorpholino)-1,3,5-triazin-2-yl)pyridin-2-amine (PQR626), a Potent, Orally Available, and Brain-Penetrant mTOR Inhibitor for the Treatment of Neurological Disorders

Journal of medicinal chemistry, 2020-11, Vol.63 (22), p.13595-13617

2020

Volltextzugriff (PDF)

4-Methylen-1-cyclopentene aus Methylencyclopropanen und Alkinyl-trimethylsilanen

Angewandte Chemie, 1985-04, Vol.97 (4), p.333-334

1985

Volltextzugriff (PDF)

4‐Methylen‐1‐cyclopentene aus Methylencyclopropanen und Alkinyl‐trimethylsilanen

Angewandte Chemie, 1985-04, Vol.97 (4), p.333-334

1985

Volltextzugriff (PDF)

4-Methylene-1-cyclopentenes from Methylenecyclopropanes and Alkynyltrimethylsilanes

Angewandte Chemie (International ed.), 1985-04, Vol.24 (4), p.316-317

1985

Volltextzugriff (PDF)

5‑(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology

Journal of medicinal chemistry, 2017-09, Vol.60 (17), p.7524-7538

2017

Volltextzugriff (PDF)

5-Alkylidene-hexahydro-1H-cyclopenta[c]pyrrol-1,3-diones by nickel(0) or palladium(0) catalyzed [3+2] cycloaddition of methylenecyclopropanes with maleimides

Tetrahedron, 1989, Vol.45 (10), p.2887-2894

1989

Volltextzugriff (PDF)

7. The vasculopathy of JDM; evidence of persistent endothelial injury, hypercoagulability, subclinical inflammation and increased arterial stiffness

Rheumatology (Oxford, England), 2017-12, Vol.56 (suppl_7)

2017

Volltextzugriff (PDF)

8th GCC: consolidated feedback to US FDA on the 2013 draft FDA guidance on bioanalytical method validation

Bioanalysis, 2014-01, Vol.6 (22), p.2957-2963

2014

Volltextzugriff (PDF)

9.4T and 17.6T MRI of Retinoblastoma: Ex Vivo evaluation of microstructural anatomy and disease extent compared with histopathology

Journal of magnetic resonance imaging, 2018-06, Vol.47 (6), p.1487-1497

2018

Volltextzugriff (PDF)

Abbildungsnachweis

Krankenhaus- und Praxishygiene, 2022, p.XIX-XIX

Fourth Edition, 2022

Volltextzugriff (PDF)

Abelard, Peter

The Oxford Guide to the Historical Reception of Augustine, 2013

1 ed., 2013

Volltextzugriff (PDF)

1 – 25 von 2.741

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.294)
Mit Volltextzugriff
(2.371)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.674)
Life Sciences & Biomedicine
(1.379)
Humans
(1.027)
Female
(589)
Male
(517)
Middle Aged
(357)
Biological And Medical Sciences
(325)
Aged
(304)
Adult
(303)
Animals
(265)
Medical Sciences
(244)
Oncology
(198)
Physical Sciences
(185)
Science & Technology - Other Topics
(142)
Risk Factors
(134)
Biochemistry & Molecular Biology
(132)
Patients
(132)
Multidisciplinary Sciences
(121)
Aged, 80 And Over
(120)
Neurosciences & Neurology
(119)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(32)
... seit 30 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

A 0/1h-algorithm using cardiac myosin-binding protein C for early diagnosis of myocardial infarction

1,3,5-Triphosphabicyclo[3.1.0]hexene-η3,η1-diyl Hafnium Complexes: Structure and Reactivity

13C tracer analysis reveals the landscape of metabolic checkpoints in human CD8+ T cell differentiation and exhaustion

14th International Conference of Archaeological Prospection

16(th) IHIW: extending the number of resources and bioinformatics analysis for the investigation of HLA rare alleles

181 INTRO-study: intraperitoneal infusion of allogeneic stem-cell derived natural killer cells in recurrent ovarian carcinoma patients

The 1976C>T polymorphism in the adenosine A2A receptor gene does not affect the vasodilator response to adenosine in humans in vivo

2019 EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older

The 22G>A polymorphism in the adenosine deaminase gene impairs catalytic function but does not affect reactive hyperaemia in humans in vivo

2937: Dose deposition in sub-regions of breast relates to acute and persistent pain after radiotherapy

320. PEDIATRIC OPEN-LABEL CLINICAL STUDY OF RITUXIMAB FOR THE TREATMENT OF GRANULOMATOSIS WITH POLYANGIITIS AND MICROSCOPIC POLYANGIITIS

IL‐33 polymorphisms are associated with increased risk of hay fever and reduced regulatory T cells in a birth cohort

336.5: Modifying The Porcine Genome for Xeno-organ Transplantation

385 EFFECT OF RENAL NERVE ABLATION ON ARTERIAL STIFFNESS IN RESISTANT HYPERTENSION

4‑(Difluoromethyl)-5-(4-((3R,5S)‑3,5-dimethylmorpholino)-6-((R)‑3-methylmorpholino)-1,3,5-triazin-2-yl)pyridin-2-amine (PQR626), a Potent, Orally Available, and Brain-Penetrant mTOR Inhibitor for the Treatment of Neurological Disorders

4-Methylen-1-cyclopentene aus Methylencyclopropanen und Alkinyl-trimethylsilanen

4‐Methylen‐1‐cyclopentene aus Methylencyclopropanen und Alkinyl‐trimethylsilanen

4-Methylene-1-cyclopentenes from Methylenecyclopropanes and Alkynyltrimethylsilanes

5‑(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology

5-Alkylidene-hexahydro-1H-cyclopenta[c]pyrrol-1,3-diones by nickel(0) or palladium(0) catalyzed [3+2] cycloaddition of methylenecyclopropanes with maleimides

7. The vasculopathy of JDM; evidence of persistent endothelial injury, hypercoagulability, subclinical inflammation and increased arterial stiffness

8th GCC: consolidated feedback to US FDA on the 2013 draft FDA guidance on bioanalytical method validation

9.4T and 17.6T MRI of Retinoblastoma: Ex Vivo evaluation of microstructural anatomy and disease extent compared with histopathology

Abbildungsnachweis

Abelard, Peter

Suchergebnisse filtern